A review of new science, in plain language

Science  ·  3 September 2026  ·  From issue 32

(Un)intended consequences of mass-prescribing GLP-1s

Fair access to popular weight loss drugs faces threats from competing business interests.

Luc L. Hagenaars, Laura A. Schmidt.

Integrity screen: passed (3 checks) Checked 10 September 2026. Read the source

The plain-language reading of this paper is in the full issue, for subscribers.

Read the full issue

Get it free, every two days

Five papers free every issue, about 15 emails a month. No spam. Leave in one click.

Also in issue 32 15 papers
More from Science